Cytokine receptor dimerization and activation: prospects for small molecule agonists
- 1 March 2001
- journal article
- review article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 9 (3) , 557-562
- https://doi.org/10.1016/s0968-0896(00)00276-5
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Signal Transduction in the Erythropoietin Receptor SystemExperimental Cell Research, 1999
- MoistureChemical & Engineering News, 1999
- Tumor necrosis factor receptor family members in the immune systemSeminars in Immunology, 1998
- An antagonist peptide–EPO receptor complex suggests that receptor dimerization is not sufficient for activationNature Structural & Molecular Biology, 1998
- DIMERIZATION AS A REGULATORY MECHANISM IN SIGNAL TRANSDUCTIONAnnual Review of Immunology, 1998
- Peptide Agonist of the Thrombopoietin Receptor as Potent as the Natural CytokineScience, 1997
- Activation of the Erythropoietin (EPO) Receptor by Bivalent Anti-EPO Receptor AntibodiesPublished by Elsevier ,1996
- Small Peptides as Potent Mimetics of the Protein Hormone ErythropoietinScience, 1996
- Dimerization of the Extracellular Domain of the Erythropoietin (EPO) Receptor by EPO: One High-Affinity and One Low-Affinity InteractionBiochemistry, 1996
- Cytokine receptor signallingNature, 1995